Regents Professor shares insight on mRNA technology and genome sequencing
The treatment uses a type of CRISPR to target viral RNA and appears to stop replication of both viruses in the lungs.
Two researchers in the Coulter Department of Biomedical Engineering work with the components that make up the vaccine and say they’re safe and effective.
BME researcher developing low-cost, self-applied, durable system based on mRNA
Getting antibodies directly to the lungs protected mice from the virus.